Maller, J J
Broadhouse, K
Rush, A J
Gordon, E
Koslow, S
Grieve, S M
Article History
Received: 6 June 2017
Revised: 29 August 2017
Accepted: 14 September 2017
First Online: 14 November 2017
Conflict of Interest
: EG is the CEO of Brain Resource Ltd and has significant equity and stock options in the company. AJR has received consulting fees from Brain Resource Ltd, Duke-NUS, Eli Lilly, Emmes Corp, Liva-Nova Inc., Medavante Inc., Otsuka Pharmaceuticals USA, Santium Inc., Sunovion, Takeda USA, University of Texas Southwestern Med Cntr.; royalties from Guilford Publications and the University of Texas Southwestern Medical Center at Dallas. SK serves on the Board of Directors of MyBrainSolutions and receive compensation in cash and stock options; serve as a private consultant for grant mentoring and preparation to staff at the University of Miami, Miller School of Medicine, Miami, Florida, and Louisiana State University Health Science Center; serves as a Director for the BRAINnet Database. SMG has previously received fees as a consultant for Brain Resource Ltd. The remaining authors declare no conflict of interest.